documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
9,397 rows where agency_id = "FDA", document_type = "Other" and posted_year = 2016 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: open_for_comment, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2015-N-0101-1319 | FDA | FDA-2015-N-0101 | Advice Letter from FDA CDER to American Chemistry Council | Other | Letter(s) | 2016-12-30T05:00:00Z | 2016 | 12 | 2016-12-30T05:00:00Z | 2016-12-30T18:11:04Z | 0 | 0 | 0900006482442595 | ||
| FDA-2015-D-0025-0016 | FDA | FDA-2015-D-0025 | Medical Device Accessories – Describing Accessories and Classification Pathway for New Accessory Types Guidance for Industry and Food and Drug Administration Staff | Other | Guidance | 2016-12-30T05:00:00Z | 2016 | 12 | 2016-12-30T05:00:00Z | 2024-11-11T21:31:30Z | 1 | 0 | 09000064824410cc | ||
| FDA-2016-D-0269-0113 | FDA | FDA-2016-D-0269 | Prescription Requirement Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry | Other | Guidance | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2024-11-12T06:18:06Z | 1 | 0 | 090000648243ddab | ||
| FDA-2013-E-0397-0007 | FDA | FDA-2013-E-0397 | Letter from U.S. Patent and Trademark Office | Other | Letter(s) | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2016-12-29T17:24:51Z | 0 | 0 | 090000648243dfe0 | ||
| FDA-2016-V-4616-0002 | FDA | FDA-2016-V-4616 | Acknowledgement Letter from FDA DDM to LASERSLIVE | Other | Acknowledgement Letter/Receipt | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2016-12-29T22:41:32Z | 0 | 0 | 090000648243f2c9 | ||
| FDA-2016-V-4592-0002 | FDA | FDA-2016-V-4592 | Acknowledgement Letter from FDA DDM to FOH Ninja | Other | Acknowledgement Letter/Receipt | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2016-12-29T22:38:52Z | 0 | 0 | 090000648243c203 | ||
| FDA-2014-E-0265-0008 | FDA | FDA-2014-E-0265 | Letter from U.S. Patent and Trademark Office | Other | Letter(s) | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2016-12-29T17:00:31Z | 0 | 0 | 090000648243db42 | ||
| FDA-2000-D-0103-0010 | FDA | Botanical Drug Development FDA-2000-D-0103 | Botanical Drug Development Guidance for Industry | Other | Guidance | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2024-11-12T06:17:07Z | 1 | 0 | 090000648243ddaf | ||
| FDA-2016-V-4616-0001 | FDA | FDA-2016-V-4616 | Variance Application from LASERSLIVE | Other | Application for Variance (VAR) | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2016-12-29T22:40:37Z | 0 | 0 | 090000648243f28d | ||
| FDA-2013-E-0687-0007 | FDA | FDA-2013-E-0687 | Letter from U.S. Patent and Trademark Office | Other | Letter(s) | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2016-12-29T17:16:50Z | 0 | 0 | 090000648243df84 | ||
| FDA-2016-N-3389-0394 | FDA | FDA-2016-N-3389 | Request to Extend Comment Period from Grocery Manufacturers Association | Other | Electronic Regulation from Form | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2016-12-29T17:19:26Z | 0 | 0 | 0900006482432fb6 | ||
| FDA-2016-D-4317-0002 | FDA | FDA-2016-D-4317 | Draft Guidance for Compounding and Repackaging of Radiopharmaceuticals By Outsourcing Facilities Guidance for Industry | Other | Guidance | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2017-02-28T04:59:59Z | 2019-08-21T15:09:05Z | 0 | 0 | 090000648243ddb2 | |
| FDA-2016-V-4617-0001 | FDA | FDA-2016-V-4617 | Variance Application from Redwolf Entertainment | Other | Application for Variance (VAR) | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2016-12-29T23:09:01Z | 0 | 0 | 090000648243f1f6 | ||
| FDA-2016-D-2335-0730 | FDA | FDA-2016-D-2335 | Request to Extend Comment Period from Herbalife International of America, Inc. | Other | Request for Extension | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2016-12-29T18:07:39Z | 0 | 0 | 0900006482432aa1 | ||
| FDA-2016-D-2495-0014 | FDA | FDA-2016-D-2495 | Submission of Warning Plans for Cigars Guidance for Industry | Other | Guidance | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2024-11-07T23:52:28Z | 1 | 0 | 090000648243da71 | ||
| FDA-2016-V-4592-0001 | FDA | FDA-2016-V-4592 | Variance Application from FOH Ninja | Other | Application for Variance (VAR) | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2016-12-29T22:38:47Z | 0 | 0 | 090000648243c201 | ||
| FDA-2014-E-0126-0011 | FDA | FDA-2014-E-0126 | Letter from U.S. Patent and Trademark Office | Other | Letter(s) | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2016-12-29T17:22:08Z | 0 | 0 | 090000648243dfb9 | ||
| FDA-2016-V-4617-0002 | FDA | FDA-2016-V-4617 | Acknowledgement Letter from FDA DDM to Redwolf Entertainment | Other | Acknowledgement Letter/Receipt | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2016-12-29T23:09:07Z | 0 | 0 | 090000648243f1f9 | ||
| FDA-2013-E-0968-0007 | FDA | FDA-2013-E-0968 | Letter from U.S. Patent and Trademark Office | Other | Letter(s) | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2016-12-29T17:27:19Z | 0 | 0 | 090000648243dfe2 | ||
| FDA-2013-E-0785-0007 | FDA | FDA-2013-E-0785 | Letter from U.S. Patent and Trademark Office | Other | Letter(s) | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2016-12-29T17:29:41Z | 0 | 0 | 090000648243dfe5 | ||
| FDA-2014-D-0234-0030 | FDA | FDA-2014-D-0234 | Clinical Pharmacology Data to Support a Demonstration of Biosimilarity to a Reference Product Guidance for Industry | Other | Guidance | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2024-11-12T06:15:55Z | 1 | 0 | 090000648243d98f | ||
| FDA-2016-D-4318-0002 | FDA | FDA-2016-D-4318 | Compounding and Repackaging of Radiopharmaceuticals by State-Licensed Nuclear Pharmacies and Federal Facilities Guidance for Industry DRAFT GUIDANCE | Other | Guidance | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2017-02-28T04:59:59Z | 2024-11-12T06:15:53Z | 1 | 0 | 090000648243dd0f | |
| FDA-2013-E-1302-0007 | FDA | FDA-2013-E-1302 | Letter from U.S. Patent and Trademark Office | Other | Letter(s) | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2016-12-29T17:19:45Z | 0 | 0 | 090000648243dfb6 | ||
| FDA-2016-P-4388-0002 | FDA | FDA-2016-P-4388 | Acknowledgment Letter from FDA DDM to Dr. S. Varghese | Other | Acknowledgement Letter/Receipt | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2016-12-29T17:33:53Z | 0 | 0 | 090000648240c140 | ||
| FDA-2013-E-0475-0007 | FDA | FDA-2013-E-0475 | Letter from U.S. Patent and Trademark Office | Other | Letter(s) | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2016-12-29T17:06:41Z | 0 | 0 | 090000648243db48 | ||
| FDA-2016-P-4388-0001 | FDA | FDA-2016-P-4388 | Citizen Petition from Dr. S. Varghese | Other | Citizen Petition | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2017-06-27T03:59:59Z | 2020-12-11T15:25:03Z | 0 | 0 | 090000648240c13d | |
| FDA-2009-D-0524-0033 | FDA | FDA-2009-D-0524 | Listing of Ingredients in Tobacco Products (Revised)* Guidance for Industry | Other | Guidance | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2024-11-11T21:31:27Z | 1 | 0 | 090000648243d90e | ||
| FDA-2014-E-0102-0010 | FDA | FDA-2014-E-0102 | Letter from U.S. Patent and Trademark Office | Other | Letter(s) | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2016-12-29T17:09:08Z | 0 | 0 | 090000648243df82 | ||
| FDA-2014-D-1953-0003 | FDA | FDA-2014-D-1953 | Providing Regulatory Submissions in Electronic Format—Submission of Manufacturing Establishment Information Guidance for Industry | Other | 2016-12-29T00:00:00Z | 2016 | 12 | 2024-11-12T06:18:05Z | 0 | 1 | 090000648243d87f | ||||
| FDA-2016-P-4587-0001 | FDA | FDA-2016-P-4587 | Citizen Petition from Mallinckrodt Pharmaceuticals | Other | Citizen Petition | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2017-06-27T03:59:59Z | 2017-05-13T21:06:17Z | 0 | 0 | 090000648243b8f5 | |
| FDA-2013-E-1652-0007 | FDA | FDA-2013-E-1652 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T15:40:58Z | 0 | 0 | 090000648243b099 | ||
| FDA-2013-E-1435-0007 | FDA | FDA-2013-E-1435 | Notice of Final Determination Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T13:27:17Z | 0 | 0 | 090000648243a249 | ||
| FDA-2016-P-4584-0001 | FDA | FDA-2016-P-4584 | Citizen Petition from Public Citizens Health Research Group | Other | Citizen Petition | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2017-05-31T03:59:59Z | 2016-12-28T21:49:56Z | 0 | 0 | 090000648243b3c0 | |
| FDA-2014-P-1685-0004 | FDA | FDA-2014-P-1685 | Petition Denial Letter | Other | Denial of Petition | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T18:59:58Z | 0 | 0 | 090000648243b95d | ||
| FDA-2014-E-0307-0008 | FDA | FDA-2014-E-0307 | Notice of Final Determination Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T14:15:11Z | 0 | 0 | 090000648243a443 | ||
| FDA-2013-E-1437-0007 | FDA | FDA-2013-E-1437 | Noice of FInal Determination Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T13:58:12Z | 0 | 0 | 090000648243a43d | ||
| FDA-2016-P-4585-0001 | FDA | FDA-2016-P-4585 | Citizen Petition from Acorda Therapeutics, Inc | Other | Citizen Petition | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2017-06-27T03:59:59Z | 2016-12-28T21:50:52Z | 0 | 0 | 090000648243b802 | |
| FDA-2013-E-0218-0004 | FDA | FDA-2013-E-0218 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T12:48:16Z | 0 | 0 | 0900006482439154 | ||
| FDA-2014-E-0279-0008 | FDA | FDA-2014-E-0279 | Notice of Final Determination Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T19:22:15Z | 0 | 0 | 090000648243b985 | ||
| FDA-2016-E-4590-0001 | FDA | FDA-2016-E-4590 | Patent Extension Application from Cooley LLP (on behalf of Collegium Pharmaceutical, Inc) | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T18:48:24Z | 0 | 0 | 090000648243b930 | ||
| FDA-2016-E-4588-0001 | FDA | FDA-2016-E-4588 | Patent Extension Application from Cooley LLP (on behalf of Collegium Pharmaceutical, Inc) | Other | Application | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2017-07-18T11:56:50Z | 0 | 0 | 090000648243b645 | ||
| FDA-2014-E-0182-0008 | FDA | FDA-2014-E-0182 | Notice of Final Determination Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T14:43:08Z | 0 | 0 | 090000648243a977 | ||
| FDA-2016-P-4585-0002 | FDA | FDA-2016-P-4585 | Acknowledgement Letter from FDA DDM to Acorda Therapeutics, Inc. | Other | Acknowledgement Letter/Receipt | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T21:50:55Z | 0 | 0 | 090000648243b804 | ||
| FDA-2011-E-0117-0010 | FDA | FDA-2011-E-0117 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T16:02:09Z | 0 | 0 | 090000648243ac83 | ||
| FDA-2013-E-1433-0007 | FDA | FDA-2013-E-1433 | Notice of Final Determination Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T19:30:45Z | 0 | 0 | 090000648243b987 | ||
| FDA-2016-E-0629-0004 | FDA | FDA-2016-E-0629 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T19:08:09Z | 0 | 0 | 090000648243b936 | ||
| FDA-2014-E-0074-0008 | FDA | FDA-2014-E-0074 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T15:15:46Z | 0 | 0 | 090000648243af7e | ||
| FDA-2016-E-4588-0002 | FDA | FDA-2016-E-4588 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T17:45:01Z | 0 | 0 | 090000648243b649 | ||
| FDA-2016-E-4589-0001 | FDA | FDA-2016-E-4589 | Patent Extension Application from Cooley LLP (on behalf of Collegium Pharmaceutical, Inc) | Other | Application | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T17:56:06Z | 0 | 0 | 090000648243b75c | ||
| FDA-2016-P-4587-0002 | FDA | FDA-2016-P-4587 | Acknowledgement Letter from FDA DDM to Mallinckrodt Pharmaceuticals | Other | Acknowledgement Letter/Receipt | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T21:51:19Z | 0 | 0 | 090000648243b8f7 | ||
| FDA-2013-E-0264-0004 | FDA | FDA-2013-E-0264 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T13:18:55Z | 0 | 0 | 090000648243a243 | ||
| FDA-2015-D-2537-0108 | FDA | FDA-2015-D-2537 | Request to Extend Comment Period from CGA and GAWDA | Other | Request for Extension | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T16:49:10Z | 0 | 0 | 090000648243b643 | ||
| FDA-2016-E-0627-0004 | FDA | FDA-2016-E-0627 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T12:38:01Z | 0 | 0 | 0900006482439152 | ||
| FDA-2016-E-4589-0002 | FDA | FDA-2016-E-4589 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T18:00:41Z | 0 | 0 | 090000648243b3fe | ||
| FDA-2014-E-0131-0009 | FDA | FDA-2014-E-0131 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T15:30:49Z | 0 | 0 | 090000648243b03b | ||
| FDA-2016-P-4584-0002 | FDA | FDA-2016-P-4584 | Acknowledgement Letter from FDA DDM to Public Citizens Health Research Group | Other | Acknowledgement Letter/Receipt | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T21:50:00Z | 0 | 0 | 090000648243b3c2 | ||
| FDA-2013-E-0263-0004 | FDA | FDA-2013-E-0263 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T19:15:08Z | 0 | 0 | 090000648243b983 | ||
| FDA-2015-D-5105-0058 | FDA | FDA-2015-D-5105 | Postmarket Management of Cybersecurity in Medical Devices Guidance for Industry and Food and Drug Administration Staff | Other | Guidance | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2024-11-07T23:52:14Z | 1 | 0 | 090000648243a974 | ||
| FDA-2016-E-4590-0002 | FDA | FDA-2016-E-4590 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T18:49:00Z | 0 | 0 | 090000648243b933 | ||
| FDA-2015-D-2537-0107 | FDA | FDA-2015-D-2537 | Request to Extend Comment Period from Cook Group, Inc. | Other | Request for Extension | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T16:46:19Z | 0 | 0 | 090000648243b1a1 | ||
| FDA-2014-E-0299-0008 | FDA | FDA-2014-E-0299 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-28T05:00:00Z | 2016 | 12 | 2016-12-28T05:00:00Z | 2016-12-28T15:52:28Z | 0 | 0 | 090000648243b09e | ||
| FDA-2016-V-4377-0002 | FDA | FDA-2016-V-4377 | Acknowledgment Letter from FDA DDM to Eric Cwiak | Other | Acknowledgement Letter/Receipt | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T05:00:00Z | 2017-11-29T15:46:13Z | 0 | 0 | 090000648240be6d | ||
| FDA-2016-V-4377-0001 | FDA | FDA-2016-V-4377 | Variance Application for Eric Cwiak | Other | Application for Variance (VAR) | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T05:00:00Z | 2017-11-29T15:46:19Z | 0 | 0 | 090000648240b853 | ||
| FDA-2016-V-4390-0002 | FDA | FDA-2016-V-4390 | Acknowledgement Letter from FDA DDM to Jellybeams | Other | Acknowledgement Letter/Receipt | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T05:00:00Z | 2016-12-27T22:47:31Z | 0 | 0 | 090000648240ea4a | ||
| FDA-2016-M-4529-0001 | FDA | FDA-2016-M-4529 | Premarket Approval Response from FDA CDRH to Aptima HIV-1 Quant Assay | Other | Approval | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T05:00:00Z | 2016-12-27T12:54:19Z | 0 | 0 | 0900006482436620 | ||
| FDA-2014-E-0950-0004 | FDA | FDA-2014-E-0950 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T05:00:00Z | 2016-12-27T19:30:41Z | 0 | 0 | 09000064824384fb | ||
| FDA-2016-V-4390-0001 | FDA | FDA-2016-V-4390 | Variance Application from Jellybeams | Other | Application for Variance (VAR) | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T05:00:00Z | 2016-12-27T22:47:21Z | 0 | 0 | 090000648240ea48 | ||
| FDA-2014-E-0944-0004 | FDA | FDA-2014-E-0944 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T05:00:00Z | 2016-12-27T19:10:39Z | 0 | 0 | 09000064824384bf | ||
| FDA-2016-D-1495-0015 | FDA | FDA-2016-D-1495 | Guidance for Industry on Factors to Consider Regarding Benefit-Risk in Medical Device Product Availability, Compliance, and Enforcement Decisions | Other | Guidance | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T05:00:00Z | 2024-11-11T21:31:40Z | 1 | 0 | 09000064824378a1 | ||
| FDA-2016-V-4391-0001 | FDA | FDA-2016-V-4391 | Variance Application from JMH Productions LLC | Other | Application for Variance (VAR) | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T05:00:00Z | 2016-12-27T22:49:37Z | 0 | 0 | 090000648240f0f8 | ||
| FDA-2016-V-4391-0002 | FDA | FDA-2016-V-4391 | Acknowledgement Letter from FDA DDM to JMH Productions LLC | Other | Acknowledgement Letter/Receipt | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T05:00:00Z | 2016-12-27T22:49:45Z | 0 | 0 | 090000648240f0fa | ||
| FDA-2012-D-1002-0010 | FDA | FDA-2012-D-1002 | Draft Guidance for Questions and Answers Regarding Food Facility Registration (Seventh Edition) | Other | Guidance | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T05:00:00Z | 2024-11-07T23:51:42Z | 1 | 0 | 09000064824379f1 | ||
| FDA-2014-E-0943-0004 | FDA | FDA-2014-E-0943 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T05:00:00Z | 2016-12-27T19:43:29Z | 0 | 0 | 09000064824384fd | ||
| FDA-2015-E-4615-0004 | FDA | FDA-2015-E-4615 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T05:00:00Z | 2016-12-27T18:45:29Z | 0 | 0 | 0900006482438638 | ||
| FDA-2016-E-2379-0004 | FDA | FDA-2016-E-2379 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T05:00:00Z | 2016-12-27T18:16:55Z | 0 | 0 | 0900006482438391 | ||
| FDA-2015-E-4727-0004 | FDA | FDA-2015-E-4727 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T05:00:00Z | 2016-12-27T18:56:11Z | 0 | 0 | 090000648243847b | ||
| FDA-2016-E-1888-0004 | FDA | FDA-2016-E-1888 | Letter from U.S. Patent and Trademark Office to FDA | Other | Letter(s) | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T05:00:00Z | 2016-12-27T18:01:50Z | 0 | 0 | 09000064824380f0 | ||
| FDA-2014-E-0945-0004 | FDA | FDA-2014-E-0945 | Letter from U.S. Patent and Trademark Office to CDER | Other | Letter(s) | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T05:00:00Z | 2016-12-27T19:57:05Z | 0 | 0 | 0900006482438900 | ||
| FDA-2014-E-0940-0004 | FDA | FDA-2014-E-0940 | Letter from U.S. Patent and Trademark Office | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T16:23:22Z | 0 | 0 | 0900006482434339 | ||
| FDA-2015-E-0640-0004 | FDA | FDA-2015-E-0640 | Letter from U.S. Patent and Trademark Office to FDA | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T16:54:27Z | 0 | 0 | 09000064824343c6 | ||
| FDA-2014-E-2362-0004 | FDA | FDA-2014-E-2362 | Letter from U.S. Patent and Trademark Office | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T16:40:53Z | 0 | 0 | 09000064824345a1 | ||
| FDA-2016-V-4097-0008 | FDA | FDA-2016-V-4097 | Variance Approval Letter from FDA CDRH to Carestream Dental Company (Trophy) | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T19:06:01Z | 0 | 0 | 0900006482434a30 | ||
| FDA-2015-E-1179-0004 | FDA | FDA-2015-E-1179 | Letter from U.S. Patent and Trademark Office to FDA | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T15:58:24Z | 0 | 0 | 0900006482433cb3 | ||
| FDA-2015-E-2604-0004 | FDA | FDA-2015-E-2604 | Letter from U.S. Patent and Trademark Office to FDA | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T18:11:12Z | 0 | 0 | 09000064824344cc | ||
| FDA-2014-E-2363-0004 | FDA | FDA-2014-E-2363 | Letter from U.S. Patent and Trademark Office to FDA | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T17:43:43Z | 0 | 0 | 09000064824344c4 | ||
| FDA-2014-E-1653-0004 | FDA | FDA-2014-E-1653 | Letter from U.S. Patent and Trademark Office | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T16:37:41Z | 0 | 0 | 090000648243459f | ||
| FDA-2015-E-3854-0004 | FDA | FDA-2015-E-3854 | Letter from U.S. Patent and Trademark Office | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T16:08:26Z | 0 | 0 | 0900006482433cb9 | ||
| FDA-2015-E-2722-0006 | FDA | FDA-2015-E-2722 | Letter from U.S. Patent and Trademark Office to FDA | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T17:05:59Z | 0 | 0 | 090000648243468f | ||
| FDA-2016-E-0118-0004 | FDA | FDA-2016-E-0118 | Letter from U.S. Patent and Trademark Office | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T16:26:39Z | 0 | 0 | 090000648243436b | ||
| FDA-2015-E-4696-0004 | FDA | FDA-2015-E-4696 | Letter from U.S. Patent and Trademark Office | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T16:17:02Z | 0 | 0 | 0900006482434331 | ||
| FDA-2014-E-2326-0004 | FDA | FDA-2014-E-2326 | Letter from U.S. Patent and Trademark Office to FDA | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T16:36:59Z | 0 | 0 | 090000648243459d | ||
| FDA-2015-E-4020-0004 | FDA | FDA-2015-E-4020 | Letter from U.S. Patent and Trademark Office | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T16:32:03Z | 0 | 0 | 0900006482434387 | ||
| FDA-2015-E-2965-0006 | FDA | FDA-2015-E-2965 | Letter from U.S. Patent and Trademark Office | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T16:29:07Z | 0 | 0 | 0900006482434383 | ||
| FDA-2015-E-4700-0004 | FDA | FDA-2015-E-4700 | Letter from U.S. Patent and Trademark Office to FDA | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T16:17:38Z | 0 | 0 | 090000648243452c | ||
| FDA-2015-E-4703-0004 | FDA | FDA-2015-E-4703 | Letter from U.S. Patent and Trademark Office to FDA | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T16:28:26Z | 0 | 0 | 0900006482434369 | ||
| FDA-2015-E-2619-0004 | FDA | FDA-2015-E-2619 | Letter from U.S. Patent and Trademark Office | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T16:43:10Z | 0 | 0 | 09000064824343c2 | ||
| FDA-2015-E-3855-0004 | FDA | FDA-2015-E-3855 | Letter from U.S. Patent and Trademark Office to FDA | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T16:07:22Z | 0 | 0 | 0900006482433cb7 | ||
| FDA-2015-E-2660-0006 | FDA | FDA-2015-E-2660 | Letter from U.S. Patent and Trademark Office to FDA | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T17:15:43Z | 0 | 0 | 0900006482434443 | ||
| FDA-2015-E-1665-0004 | FDA | FDA-2015-E-1665 | Letter from U.S. Patent and Trademark Office to FDA | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T18:01:04Z | 0 | 0 | 09000064824344c8 | ||
| FDA-2014-E-1240-0005 | FDA | FDA-2014-E-1240 | Letter from U.S. Patent and Trademark Office to FDA | Other | Letter(s) | 2016-12-23T05:00:00Z | 2016 | 12 | 2016-12-23T05:00:00Z | 2016-12-23T17:34:25Z | 0 | 0 | 0900006482434448 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);